B cell immunobiology in disease: evolving concepts from the clinic
- PMID: 16551256
- DOI: 10.1146/annurev.immunol.24.021605.090517
B cell immunobiology in disease: evolving concepts from the clinic
Abstract
The pathogenic roles of B cells in autoimmune diseases occur through several mechanistic pathways that include autoantibodies, immune complexes, dendritic and T cell activation, cytokine synthesis, chemokine-mediated functions, and ectopic neolymphogenesis. Each of these pathways participate to different degrees in autoimmune diseases. The use of B cell-targeted and B cell subset-targeted therapies in humans is illuminating the mechanisms at work in a variety of human autoimmune diseases. In this review, we highlight some of these recent findings that provide insights into both murine models of autoimmunity and human autoimmune diseases.
Similar articles
-
B cell targeted therapy in autoimmunity.J Autoimmun. 2007 Mar-May;28(2-3):62-8. doi: 10.1016/j.jaut.2007.02.001. Epub 2007 Mar 27. J Autoimmun. 2007. PMID: 17391915 Review.
-
[B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].Fukuoka Igaku Zasshi. 2005 Apr;96(4):86-92. Fukuoka Igaku Zasshi. 2005. PMID: 15991605 Review. Japanese.
-
Autoimmune syndrome after induction of neonatal tolerance to alloantigens: effects of in vivo treatment with anti-T cell subset monoclonal antibodies.J Immunol. 1987 Sep 1;139(5):1426-31. J Immunol. 1987. PMID: 3114366
-
B lymphocytes are required for development and treatment of autoimmune diseases.Ann N Y Acad Sci. 2005 Jun;1050:19-33. doi: 10.1196/annals.1313.003. Ann N Y Acad Sci. 2005. PMID: 16014517 Review.
-
Immunology. Autoreactive B cells migrate into T cell territory.Science. 2002 Sep 20;297(5589):2006-8. doi: 10.1126/science.1077011. Science. 2002. PMID: 12242429 No abstract available.
Cited by
-
Pragmatic approaches to therapy for systemic lupus erythematosus.Nat Rev Rheumatol. 2014 Feb;10(2):97-107. doi: 10.1038/nrrheum.2013.157. Epub 2013 Oct 29. Nat Rev Rheumatol. 2014. PMID: 24166241 Review.
-
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.Clin Microbiol Rev. 2020 Jun 10;33(3):e00035-19. doi: 10.1128/CMR.00035-19. Print 2020 Jun 17. Clin Microbiol Rev. 2020. PMID: 32522746 Free PMC article. Review.
-
Analysis of interleukin 7 and platelet-derived growth factor-BB mRNA expression as potential markers in erythema nodosum leprosum.Dermatol Reports. 2023 Sep 12;16(1):9773. doi: 10.4081/dr.2023.9773. eCollection 2024 Mar 12. Dermatol Reports. 2023. PMID: 38623372 Free PMC article.
-
B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies.Nat Rev Neurol. 2021 Jul;17(7):399-414. doi: 10.1038/s41582-021-00498-5. Epub 2021 Jun 1. Nat Rev Neurol. 2021. PMID: 34075251 Review.
-
Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis.Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4658-63. doi: 10.1073/pnas.1001074107. Epub 2010 Feb 22. Proc Natl Acad Sci U S A. 2010. PMID: 20176942 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical